Literature DB >> 7820218

Impaired counterregulatory hormone responses to hypoglycemia in children and adolescents with new onset IDDM.

R P Hoffman1, S Arslanian, A L Drash, D J Becker.   

Abstract

Children with long-standing IDDM have impaired counterregulatory responses to hypoglycemia. To determine whether children with new onset IDDM also have altered counterregulation, we studied the counterregulatory responses to hypoglycemia in twenty children with new onset IDDM (5-6 days, age 12.6 +/- 2.9 yr, mean +/- SD), and compared these responses to 47 subjects with long-standing IDDM (duration 7.8 +/- 3.6 yr, age 15.3 +/- 2.5 yr) and 21 controls (age 14.2 +/- 2.8 yr). Six new onset subjects were restudied three months later during their remission. Glucose nadir in new onset (2.7 +/- 0.1 mmol.l-1) was similar to controls (2.4 +/- 0.1 mmol.l-1), but was higher than in long-standing IDDM (2.2 +/- 0.1 mmol.l-1). Both groups of diabetic subjects had lower glucagon responses to hypoglycemia than controls (p < 0.005). Glucagon responses in new and long-standing diabetes did not differ. Epinephrine was diminished in new IDDM compared to controls (p < 0.01). Glucose recovery was faster in new onset than in long-standing IDDM (p < 0.001) and the same as in controls. Responses remained diminished 3 months after diagnosis despite increased C-peptide and lower glycosylated hemoglobin. Thus, children with IDDM have diminished counterregulatory responses to hypoglycemia at diagnosis, that are similar to those in long-standing IDDM. The reasons for this impairment and its clinical application in childhood require further investigation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7820218     DOI: 10.1515/jpem.1994.7.3.235

Source DB:  PubMed          Journal:  J Pediatr Endocrinol


  10 in total

1.  Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus.

Authors:  Ana Maria Arbelaez; Dongyuan Xing; Philip E Cryer; Craig Kollman; Roy W Beck; Jennifer Sherr; Katrina J Ruedy; William V Tamborlane; Nelly Mauras; Eva Tsalikian; Darrell M Wilson; Neil H White
Journal:  Pediatr Diabetes       Date:  2013-08-28       Impact factor: 4.866

2.  System-level control to optimize glucagon counterregulation by switch-off of α-cell suppressing signals in β-cell deficiency.

Authors:  Leon S Farhy; Anthony L McCall
Journal:  J Diabetes Sci Technol       Date:  2009-01

Review 3.  Optimizing reduction in basal hyperglucagonaemia to repair defective glucagon counterregulation in insulin deficiency.

Authors:  L S Farhy; A L McCall
Journal:  Diabetes Obes Metab       Date:  2011-10       Impact factor: 6.577

4.  Amplification of pulsatile glucagon counterregulation by switch-off of alpha-cell-suppressing signals in streptozotocin-treated rats.

Authors:  Leon S Farhy; Zhongmin Du; Qiang Zeng; Paula P Veldhuis; Michael L Johnson; Kenneth L Brayman; Anthony L McCall
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-24       Impact factor: 4.310

5.  Pancreatic network control of glucagon secretion and counterregulation.

Authors:  Leon S Farhy; Anthony L McCall
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 6.  Minimizing morbidity of hypoglycemia in diabetes: a review of mini-dose glucagon.

Authors:  Stephanie T Chung; Morey W Haymond
Journal:  J Diabetes Sci Technol       Date:  2014-08-26

7.  Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes.

Authors:  Aris Siafarikas; Robert J Johnston; Max K Bulsara; Peter O'Leary; Timothy W Jones; Elizabeth A Davis
Journal:  Diabetes Care       Date:  2012-06-14       Impact factor: 19.112

8.  Association of Basal hyperglucagonemia with impaired glucagon counterregulation in type 1 diabetes.

Authors:  Leon S Farhy; Alice Chan; Marc D Breton; Stacey M Anderson; Boris P Kovatchev; Anthony L McCall
Journal:  Front Physiol       Date:  2012-02-28       Impact factor: 4.566

9.  Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes.

Authors:  Jennifer Sherr; Dongyuan Xing; Katrina J Ruedy; Roy W Beck; Craig Kollman; Bruce Buckingham; Neil H White; Larry Fox; Eva Tsalikian; Stuart Weinzimer; Ana Maria Arbelaez; William V Tamborlane
Journal:  Diabetes Care       Date:  2013-01-03       Impact factor: 19.112

10.  Dynamic changes in pancreatic endocrine cell abundance, distribution, and function in antigen-induced and spontaneous autoimmune diabetes.

Authors:  Klaus Pechhold; Xiaolong Zhu; Victor S Harrison; Janet Lee; Sagarika Chakrabarty; Kerstin Koczwara; Oksana Gavrilova; David M Harlan
Journal:  Diabetes       Date:  2009-02-19       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.